M&A Activity Hits Trillion-Dollar Mark

The July-September 2025 quarter proved exceptional for headline-grabbing deals. Tesla’s $58 billion acquisition of Rivian, the record $42 billion tie-up between Novartis and Bristol Myers Squibb, and Siemens Energy’s $26 billion bid for GE Vernova all propelled total M&A value upwards. These megadeals offset a broader downward trend in mid-market and small-cap deal activity worldwide.

“We saw deal values spike as strategic buyers and private equity firms targeted high-value assets with a focus on transformative, future-proof industries,” observed Sarah Hughes, Global Co-Head of M&A at Barclays. “Yet in many sectors, uncertainty and higher interest rates put the brakes on the total number of deals being done.”

According to a recent S&P Global Market Intelligence report, global deal value rose 8% year-over-year for Q3 2025, bucking a sluggish start to the year. However, the number of announced deals slid by 12%, marking the slowest pace for any quarter since 2013.

Divides Across Sectors and Markets

The divergence in M&A activity was especially pronounced when comparing regions and sectors. North America led the pack with around $710 billion in dealmaking, powered by renewed confidence among U.S. corporates and a resilient labor market. Europe, by contrast, saw uneven momentum, with deal value up but activity heavily concentrated in energy transition themes and digital infrastructure.

Asian markets faced more volatility as China’s economic trajectory slowed and outbound M&A from the region remained subdued amid continued U.S.–China political and regulatory frictions. Japan remained active in outbound deals, especially within pharmaceuticals and semiconductors, reflecting a push for international diversification.

Sectors associated with decarbonization, artificial intelligence, and healthcare innovation dominated the M&A landscape. Private equity continued to play a crucial role: PE-sponsored buyouts accounted for 27% of Q3 global deal value—near a record—despite fundraising challenges as limited partners tightened commitments amid global uncertainty.

Insurance Industry: Consolidation Accelerates

The insurance industry has seen continued consolidation as firms strive for scale, digital transformation, and exposure to growing specialty lines. Notable Q3 2025 transactions included Gallagher’s $13.5 billion acquisition of AssuredPartners, which will reportedly make Gallagher the world’s third-largest insurance broker. Similarly, U.S.-based Lincoln International moved to acquire MarshBerry, highlighting investment banking appetite for advisory and insurance distribution deals.

“Mid-sized agencies recognize that scaling through M&A is critical to maintaining competitiveness in a market shaped by technology and new risk factors,” said Michael Knight, managing director at Deloitte’s Future of Insurance group.

Headwinds: Why Many Deals Didn’t Close

Despite the glut of announcements, many proposed deals either stalled or collapsed before closing. Concerns cited by dealmakers included sustained high borrowing costs, valuation gaps between buyers and sellers, and increasingly stringent regulatory scrutiny—especially around antitrust and national security reviews in the U.S., EU, and U.K.

The U.S. Federal Trade Commission and the European Commission’s DG Competition both intensified their examination of large-scale technology and healthcare acquisitions, delaying timetables and, in some cases, blocking deals altogether. In August 2025, the DOJ signaled greater scrutiny of private equity “roll-up” strategies, causing PE sponsors to rethink aggressive consolidation in industries like healthcare and insurance.

Geopolitical risk further complicated cross-border dealmaking, particularly for transactions involving sensitive technologies and data. Dealmakers are spending more time on risk assessment and structuring transactions to withstand regulatory reviews and shifting political tides.

Looking Ahead: What Q4 May Bring

Industry analysts remain divided on the outlook for the rest of 2025. Many expect deal activity to stay robust in sectors tied to AI, digital infrastructure, climate transition, and healthcare, while overall M&A volume may lag historical norms as macro-economic uncertainty persists through early 2026.

“We expect U.S. middle-market activity to rebound modestly if the Federal Reserve signals the end of rate hikes,” projected Lee Carlton, M&A advisory partner at KPMG. “But closing the gap between buyer and seller price expectations remains key.”

In the insurance sector, analysts predict that brokers and specialty underwriters will remain sought-after targets due to the growing complexity of risk and rapid digitalization demands. Smaller players unable to keep pace are likely to seek mergers with larger, tech-forward partners.

Conclusion: Managing Risks and Seizing Opportunity

The third quarter of 2025 will be remembered for producing colossal deals—even as the backdrop for the average transaction grew more complex and uncertain. For organizations seeking growth, M&A remains a strategic lever, but success in the evolving landscape will hinge on flexible structures, sharper diligence, and a proactive approach to regulatory and geopolitical risk management.

For ongoing coverage of the global mergers and acquisitions environment—including insights, exclusive interviews, and analysis—follow our dedicated M&A news section.